LMR Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
LMR Partners's VRTX Position: Q3 2026 in Review
LMR Partners increased its Vertex Pharmaceuticals (VRTX) stake by 69% in Q3 2026, buying an estimated $3.51M and bringing the position to 16,823 shares worth $8.8M. The position accounts for 0.03% of the portfolio, ranked #507.
LMR Partners first reported a position in VRTX in Q4 2014 and has held it in 33 quarters since. The position peaked at $37.8M in Q4 2024. 1,797 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- LMR Partners held 16,823 shares of Vertex Pharmaceuticals worth $8.8M as of Q3 2026.
- LMR Partners bought 6,861 Vertex Pharmaceuticals shares in Q3 2026, an estimated $3.51M.
- Vertex Pharmaceuticals made up 0.03% of LMR Partners's portfolio in Q3 2026, its #507 holding.
- LMR Partners first reported a position in Vertex Pharmaceuticals in Q4 2014 and has held it in 33 quarters since.
- LMR Partners's Vertex Pharmaceuticals position peaked at $37.8M in Q4 2024.
- 1,797 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.